Skip to content
medical-conditions — Science — health-and-wellness — fitness-and-exercise — therapies-and-treatments — Finance — investing — Stay Ahead in VegasVibe's Stock Market Section — Technology

Medtronic issues rallying call to Intuitive Surgical, positioning Hugo as a symbol of optimism

Medical device manufacturer Medtronic's Hugo OP-Robot demonstrates success in hernia treatment trial.

,   and  Administrator
2 min read
Medtronic leads charge against Intuitive Surgical, using Hugo as a symbol of their resolve
Medtronic leads charge against Intuitive Surgical, using Hugo as a symbol of their resolve

Medtronic issues rallying call to Intuitive Surgical, positioning Hugo as a symbol of optimism

In a significant development, Medtronic's Hugo robot, a robot-assisted surgical system, has proven its potential in recent studies, challenging the market position of Intuitive Surgical's Da Vinci systems. The company received FDA approval for the use of the Hugo robot in June 2022, and investors are eagerly awaiting its upcoming U.S. approval.

The Hugo robot has demonstrated its safety and efficacy in hernia repair procedures, as evidenced by its successful completion of the Enable Hernia Repair study. This study, which is the first clinical study with an investigational device exemption for robot-assisted surgery in hernia repair indication in the U.S., exceeded its primary endpoints.

The positive results of the study could be well-received by the market, potentially leading to a rise in Medtronic's stock towards its 52-week high and beyond. The stock, with a forward P/E of 16 and a dividend yield of over three percent, could be attractive to dividend-oriented investors.

A suggested action is to consider buying Medtronic's stock and setting a stop-loss at 59.50 euros. The national principal investigator of the Enable Hernia Repair study at Duke University Hospital made a positive statement about the study, further boosting investor confidence.

Medtronic's Hugo robot has already been used in surgical procedures in certain countries outside the U.S., and its usage is expected to increase if it receives FDA approval in the coming months. The success of the Hugo robot could mark a significant shift in the surgical robot market, offering more options for medical professionals and patients alike.

The potential rise in Medtronic's stock, coupled with its attractive dividend yield, makes it an interesting investment opportunity. However, as with any investment, it's important to conduct thorough research and consider seeking advice from a financial advisor.

Read also:

Related

Latest